Literature DB >> 24118984

Clinical research priorities in emergency medicine.

Gerben Keijzers1, Ogilvie Thom, David Taylor, Jonathan Knott, David McD Taylor.   

Abstract

OBJECTIVE: To determine the clinical research priorities of Fellows of the Australasian College for Emergency Medicine (ACEM) in order to inform the strategic research agenda specific to multicentre clinical research.
METHODS: An anonymous survey of all ACEM Fellows (FACEMs) listed on the ACEM researcher database was conducted between January and March 2013.
RESULTS: Of 108 FACEMs invited to participate, 54 (50%) responded. Over half of respondents (61%) had a higher research degree but only a minority (24%) had funded research positions. The top research categories identified as priorities were resuscitation, trauma, cardiology, ED ultrasound, acute behavioural disturbance and geriatrics. The most common specific sub-categories included anterior chest pain, fluid resuscitation in trauma, and drug therapy for both atrial fibrillation and acute behavioural disturbance. Several specific research questions related to chest pain, resuscitation/sepsis, stroke, paediatrics and pulmonary embolus.
CONCLUSION: The findings provide guidance and support for research areas amenable to collaborative multicentre clinical research within emergency medicine. Discussion rounds are planned to translate these perceived research priorities to actual priorities.
© 2013 Australasian College for Emergency Medicine and Australasian Society for Emergency Medicine.

Entities:  

Keywords:  clinical trial; emergency medicine; priority; research

Mesh:

Year:  2013        PMID: 24118984     DOI: 10.1111/1742-6723.12141

Source DB:  PubMed          Journal:  Emerg Med Australas        ISSN: 1742-6723            Impact factor:   2.151


  1 in total

Review 1.  Systems for recognition and response to deteriorating emergency department patients: a scoping review.

Authors:  Julie Considine; Margaret Fry; Kate Curtis; Ramon Z Shaban
Journal:  Scand J Trauma Resusc Emerg Med       Date:  2021-05-22       Impact factor: 2.953

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.